Latest Features & Opinion

ACTRIMS Forum 2018

Live coverage of the 2018 ACTRIMS Forum, February 1-3, 2018 in San Diego, California.

International Stroke Conference 2018

Read the latest coverage of research being presented at the 2018 International Stroke Conference, January 24-26 in Los Angeles, California.

Role of Caffeine in Headache Treatment

The judicious use of caffeine as adjuvant therapy to over-the-counter pain relievers can improve or relieve pain for patients with migraine or tension-type headaches.

Physical Interventions for Huntington Disease

Interventions aimed at motor and cognitive impairments in Huntington disease may result in long-term functional improvement.

Addressing Driving Cessation in Dementia Patients

The responsibility for discussing cessation of driving in patients with mild cognitive impairment or dementia often rests on the clinician, who may have little preparation for this difficult conversation.

McDonald Criteria Revision Improves MS Diagnosis

The 2017 revision takes aim at better differentiating relapsing-remitting and primary-progressive forms of multiple sclerosis.

Neurocognitive Decline in HIV: Risk Factors

Evaluating the risk factors of neurocognitive decline in HIV.

Defining Palliative, Hospice Needs in Huntington's

Research has shown significant gaps in knowledge on palliative services among neurology residents, resulting in low referral rates.

The Effects of Sex on Parkinson's

Several studies have uncovered sex-dependent variations in the symptomatic manifestations of Parkinson disease, as well as in the response to dopamine therapies.

Updating the Clinical Picture of MSA

Although evidence of cognitive impairment in MSA is admittedly more limited than in Parkinson disease, it is now substantial enough to address modification of diagnostic criteria to include the potential for cognitive impairment at any stage of the disease.

Predicting Progression in Parkinson Disease

Numerous factors are likely contribute to the rate of progression, with different combinations of factors showing relevance for individual patients.

Exploring Behavioral Treatments for Migraine

Although pharmacotherapy remains the standard strategy for migraine management, there are many patients for whom nonpharmacological approaches are indicated.

Advance Directives for Dementia: What's the ...

Because of dementia's prolonged disease course, advance care decisions and planning are often overlooked until it is too late.
Defensive Medicine: Where Do We Draw the Line?

Defensive Medicine: Where Do We Draw the Line?

The scourge of defensive medicine — the practice of recommending tests or treatments for the purpose of avoiding or mitigating litigation — is discussed in this opinion piece.


Practice Management

Applying Conscious vs Unconscious Thinking in Your Medical Practice

Applying Conscious vs Unconscious Thinking in Your Medical Practice

This clinician discusses the application of conscious vs unconscious thinking in a medical practice.

Drug Lookup

Search our drug information database which contains an extensive list of neurologic drugs.

Browse drugs by:

Brand Generic Disease

Latest in Autism Spectrum Disorder

The Role of Gender in Familial Autism Recurrence

Although the prevalence of autism spectrum disorder is known to be more common among males than among females in the general population, information on sex-specific recurrence patterns is lacking.

Lower Autism Risk With Maternal Multivitamin Use

Lower odds of ASD with intellectual disability were seen in the maternal multivitamin use group with or without additional iron or folic acid.

Insomnia in Autism Treated With Melatonin

The treatment was effective in patients with autism with or without comorbid ADHD or neurogenetic disorders.

Latest in Neuromuscular Disorders

Charcot-Marie-Tooth Disease Severity Indicated by Plasma Neurofilament Concentration

The measurement may provide a dynamic measure of axonal damage in a disease in which neuropathy is the only neurologic manifestation.

Predicting ALS Disease Progression With Respiratory Function Decline

Patients older than 65 were more likely to have steeper declines in slow vital capacity.

Improved Outcomes in Duchenne Muscular Dystrophy With Long-Term Glucocorticoid Treatment

Patients who received deflazacort were older when they reached disease milestones compared with patients taking prednisolone or prednisone.

Sign Up for Free e-newsletters

CME Focus